Ricardo T Gazzinelli Selected Research

Infection

07/2007	Evaluation of immune responses and protection induced by A2 and nucleoside hydrolase (NH) DNA vaccines against Leishmania chagasi and Leishmania amazonensis experimental infections.
05/2007	Comparative evaluation of enzyme-linked immunosorbent assays based on crude and recombinant leishmanial antigens for serodiagnosis of symptomatic and asymptomatic Leishmania infantum visceral infections in dogs.
11/2006	Cooperative activation of TLR2 and bradykinin B2 receptor is required for induction of type 1 immunity in a mouse model of subcutaneous infection by Trypanosoma cruzi.
09/2006	Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with recombinant adenoviruses encoding amastigote surface protein-2 and trans-sialidase.
04/2006	Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of toxoplasma gondii induces immune response and protection against infection in mice.
09/2005	CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2.
12/2004	Stimulation of toll-like receptor 2 by Coxiella burnetii is required for macrophage production of pro-inflammatory cytokines and resistance to infection.
10/2004	Role of the Toll/interleukin-1 receptor signaling pathway in host resistance and pathogenesis during infection with protozoan parasites.
09/2004	Protective immunity against trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase.
07/2004	Intercellular adhesion molecule 1 deficiency leads to impaired recruitment of T lymphocytes and enhanced host susceptibility to infection with Trypanosoma cruzi.
06/2004	Infection with Toxoplasma gondii increases atherosclerotic lesion in ApoE-deficient mice.
02/2004	Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88.
01/2004	Role of Toll-like receptor 4 in induction of cell-mediated immunity and resistance to Brucella abortus infection in mice.
11/2003	Role of cytokines and major histocompatibility complex restriction in mouse resistance to infection with a natural recombinant strain (type I-III) of Toxoplasma gondii.
09/2002	Experimental chemotherapy against Trypanosoma cruzi infection: essential role of endogenous interferon-gamma in mediating parasitologic cure.
06/2002	Chemokines, inflammation and Trypanosoma cruzi infection.
02/2002	Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1.

Articles by Research Topic

Disease

17	Infection 07/2007 - 02/2002
2	Toxoplasmosis 03/2008 - 04/2002
2	Inflammation 03/2008 - 06/2002
2	Chagas Disease (American Trypanosomiasis) 04/2007 - 06/2003
1	Malaria 02/2007
1	Ocular Toxoplasmosis 07/2004
1	Fibrosarcoma 04/2003
1	Myocarditis (Carditis) 12/2002
1	Visceral Leishmaniasis (Kala Azar) 08/2002
1	Cysts 03/2002

Drug/Important Bio-Agent (IBA)

3	Interferon-gamma (Interferon, gamma)IBA 04/2007 - 02/2002
3	CytokinesIBA 12/2004 - 11/2003
2	AntigensIBA 05/2007 - 08/2002
2	trans-sialidaseIBA 09/2006 - 09/2004
1	Lipoproteins (Lipoprotein)IBA 03/2008
1	LDL Receptors (LDL Receptor)IBA 03/2008
1	DNA VaccinesIBA 07/2007
1	benzonidazole (benznidazole)IBA 04/2007
1	posaconazole FDA Link 04/2007
1	DNA (Deoxyribonucleic Acid)IBA 02/2007
1	Toll-Like Receptor 9IBA 02/2007
1	hemozoinIBA 02/2007
1	Bradykinin B2 ReceptorIBA 11/2006
1	Surface Antigens (Surface Antigen)IBA 04/2006
1	Recombinant ProteinsIBA 09/2005
1	Toll-Like Receptor 2IBA 12/2004
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 10/2004
1	Immunoglobulin A (IgA)IBA 07/2004
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 07/2004
1	Apolipoproteins E (ApoE)IBA 06/2004
1	Myeloid Differentiation Factor 88IBA 02/2004
1	Toll-Like Receptor 4IBA 01/2004
1	Proteins (Proteins, Gene)IBA 06/2003
1	Butyrates (Butyrate)IBA 04/2003
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 12/2002
1	ChemokinesIBA 06/2002
1	Immunoglobulin M (IgM)IBA 04/2002
1	AntibodiesIBA 04/2002
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2002
1	Tryptophan (L-Tryptophan)FDA Link 02/2002
1	Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA 02/2002
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 02/2002
1	KynurenineIBA 02/2002

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 09/2002